The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare Conference, the European healthcare giant noted there ...

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British drugmaker ...

Weybridge, England-based Haleon is a consumer healthcare products manufacturer that owns brands such as Sensodyne toothpaste ... a joint venture of Pfizer and GSK PLC's consumer health businesses.

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Last October, it sold a $3.3 billion stake in the maker of Sensodyne, while GSK sold its entire stake in May. J.P. Morgan and Morgan Stanley are joint global coordinators and joint bookrunners for the ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

Shares in the maker of Sensodyne, Panadol and Advil ... The sale represents nearly 7.7% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare ...